Insider filing · XGN
John Aballi
President and CEO
profile →
Exagen Inc.
XGN · Healthcare · 7 filings in 24 months
ticker →
John Aballi sold $376K of Exagen (XGN)
Executed Oct 16 2025, disclosed Oct 20 2025, 4 days later.
Value, as filed
$376K
31,787 sh × $11.82
Executed
Oct 16 2025
the trade date, as filed
Disclosed
Oct 20 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JAJohn Aballi (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Exagen Inc. (XGN). The largest single filing was $270K of XGN (34,294 sh × $7.87, as filed), executed Oct 16.
The name
XGNHealthcare · Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by John Aballi in XGN
XGNSALE
Exagen Inc.
$270K34,294 sh × $7.87
Exec Oct 16
Filed Oct 19 · 4:52 PM ET